Consensus Celanese Corporation

Equities

CE

US1508701034

Market Closed - Nyse 04:00:02 2024-04-25 pm EDT 5-day change 1st Jan Change
153.9 USD -0.99% Intraday chart for Celanese Corporation -0.47% -0.95%

Evolution of the average Target Price on Celanese Corporation

Price target over the last 5 years

History of analyst recommendation changes

f3b87932362c0dcd.T85CZ6tPLi1Xg1IIKwgl-d3lyCpRIcOLAwP-gvcBhrE.fawrId8ISHgQwCg8E19ovbmRj3g1SbLOci6dwJQyscAcujAU_HpgYCD5MQ~a8f12df612d0fe6b29f1c11d24124b04
RBC Raises Price Target on Celanese to $171 From $165, Keeps Outperform Rating MT
BofA Securities Raises Price Target on Celanese to $145 From $135, Maintains Underperform Rating MT
KeyBanc Raises Price Target on Celanese to $190 From $176, Keeps Overweight Rating MT
UBS Raises Celanese's Price Target to $199 From $175, Maintains Buy Rating MT
North American Morning Briefing : Investors on -2- DJ
JPMorgan Downgrades Celanese to Underweight From Neutral, Raises Price Target to $160 From $135 MT
ANALYST RECOMMENDATIONS : Block, Chubb, Doordash, Coinbase, Lloyds... Our Logo
Wells Fargo Raises Price Target on Celanese to $195 From $180, Maintains Overweight Rating MT
ANALYST RECOMMENDATIONS : Amex, Snowflake, Salesforce, Walmart, Nutrien... Our Logo
Deutsche Bank Adjusts Celanese Price Target to $160 From $125, Maintains Hold Rating MT
Piper Sandler Upgrades Celanese to Overweight From Neutral, Raises Price Target to $170 From $135 MT
RBC Trims Price Target on Celanese to $165 From $168, Notes 'Demand Headwinds' Likely to Persist Into Q1, Keeps Outperform Rating MT
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox... Our Logo
Baird Adjusts Celanese's Price Target to $165 From $135, Keeps Outperform Rating MT
JPMorgan Adjusts Celanese's Price Target to $135 From $125, Keeps Neutral Rating MT
Wells Fargo Adjusts Celanese's Price Target to $180 From $167, Keeps Overweight Rating MT
Tudor Pickering Holt Downgrades Celanese to Sell From Buy, Cuts Price Target to $140 From $155 MT
MORNING BID AMERICAS-Rates angst, China cut and credit card deal RE
Alembic Global Downgrades Celanese to Neutral From Overweight, Raises Price Target to $160 From $150 MT
BofA Securities Downgrades Celanese to Underperform From Neutral, Adjusts Price Target to $135 From $124 MT
RBC Raises Price Target on Celanese to $168 From $142, Keeps Outperform Rating MT
UBS Raises Celanese Price Target to $175 From $169, Maintains Buy Rating MT
Nvidia comes to Wall Street's rescue Our Logo
Keybanc Raises Price Target on Celanese to $176 From $150, Keeps Overweight Rating MT
ANALYST RECOMMENDATIONS : Blackrock, Blackstone, Exxon Mobil, Netflix, Charles Schwab... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
155.4 USD
Average target price
162 USD
Spread / Average Target
+4.23%
High Price Target
199 USD
Spread / Highest target
+28.03%
Low Price Target
138 USD
Spread / Lowest Target
-11.21%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Celanese Corporation

RBC Capital Markets
BofA Securities
KeyBanc Capital Markets
UBS
JPMorgan Chase
Wells Fargo Securities
Deutsche Bank Securities
Piper Sandler
Baird
Tudor Pickering Holt & Co.
Alembic Global
Citigroup
Barclays
Credit Suisse
BMO Capital
Vertical Research
Mizuho Securities
Morgan Stanley
Evercore ISI
Jefferies & Co.
Goldman Sachs
Wolfe Research
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. CE Stock
  4. Consensus Celanese Corporation